PDC and cancer: In summary, HIF activation via HD culture or HIF-PHD inhibition significantly impairs the ability of monocytes and macrophages to phagocytose and deplete mAb-opsonized cellular targets in vitro and diminishes direct targeting anti-cancer mAb therapy in vivo.